Study provides new insight on isolating and suppressing immune cells that could play a vital role in inhibiting other immunotherapy efforts against cancer.
Researchers find callers to a national health center were most concerned about the safety and components of vaccines based largely on old information.
The prevalence of mumps in the state is reinvigorating the question about whether a third dose of measles, mumps and rubella vaccination is warranted.
Saliva-based testing may be just as effective as serum in assessing antibodies against infections like community-acquired pneumonia, according to a new UK study.
Lead researcher hopes results of new study motivates more adults to improve vaccination compliance.
Researchers and physicians are working together to discover why adults skip recommended vaccines and what doctors can do to increase immunization rates.
A new vaccine against Alzheimer’s targets two proteins involved in the development of the disease in hopes to offer both early and late protection.
Scientists at Emory University have developed a vaccine they say may work well in preventing infection with rhinovirus—the top cause of the common cold.
The CDC reaffirms its decision to pull the intranasal vaccine, but allow vaccination in egg-allergic individuals.
Practices that scrutinize vaccine costs and plan ahead may not make much off of vaccinations, but could cut some of their losses.